Strides Pharma Science Limited
NSE: STAR BSE: STAR
NSE
782.30
-7.50 (-0.95%)
Prev Close
789.8
Open Price
789.9
Volume
430,298
Today Low / High
775.15 / 793.7
52 WK Low / High
513.05 / 1675
Range
743 - 821
BSE
780.30
-9.35 (-1.18%)
Prev Close
789.65
Open Price
795.4
Volume
12,487
Today Low / High
775.05 / 795.4
52 WK Low / High
530.7 / 1675.25
Range
741 - 819
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 782.3 (target range: 743 - 821), reflecting a change of -7.5 (-0.94961%). On the BSE, it is listed at 780.3 (target range: 741 - 819), showing a change of -9.35 (-1.18407%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
06 Jun
789.90
-0.96%
05 Jun
790.95
-0.15%
04 Jun
792.70
-0.25%
03 Jun
793.00
-0.40%
02 Jun
816.00
-2.88%
30 May
786.00
3.19%
29 May
716.00
9.12%
28 May
715.50
-0.06%
27 May
709.00
0.58%
26 May
734.70
-3.97%
23 May
733.00
-0.18%
22 May
690.10
5.83%
21 May
694.35
0.17%
20 May
690.00
-0.24%
19 May
665.00
2.99%
16 May
669.00
-1.13%
15 May
663.50
0.33%
14 May
666.00
-0.58%
13 May
657.00
1.39%
12 May
655.80
-0.68%
09 May
615.00
3.81%
Strides Pharma Science Limited Graph
Strides Pharma Science Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Strides Pharma Science Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 782.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 780.30 | 788.10 | 709.29 - 866.91 |
| 795.91 | 636.72 - 955.09 | ||
| 803.71 | 562.60 - 1,044.82 | ||
| Bearish Scenario | 780.30 | 772.50 | 695.25 - 849.75 |
| 764.69 | 611.76 - 917.63 | ||
| 756.89 | 529.82 - 983.96 |
Overview of Strides Pharma Science Limited
ISIN
INE939A01011
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
584,801
Market Cap
72,098,880,210
Last Dividend
2.5
Official Website
IPO Date
2002-06-26
DCF Diff
752.10
DCF
30
Financial Ratios Every Investor Needs
Stock Dividend of STAR
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-09 | September 09, 24 | 2.5 | 2.5 | 2024-09-09 | 2024-10-25 | |
| 2023-08-04 | August 04, 23 | 1.5 | 1.5 | 2023-08-04 | 2023-09-27 | |
| 2021-08-05 | August 05, 21 | 2.5 | 2.5 | 2021-08-06 | 2021-10-03 | |
| 2020-07-24 | July 24, 20 | 2 | 2 | 2020-07-27 | 2020-09-19 | |
| 2019-08-22 | August 22, 19 | 12 | 12 | 2019-08-23 | 2019-08-27 | 2019-07-29 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 3,891.02 Cr | 1,725.18 Cr | 2,165.84 Cr | 0.5566 | 0.00 Cr | 155.99 Cr | 522.58 Cr | -70.61 Cr | -7.76 | 376.47 Cr | -0.0181 |
| 2023-03-31 | 3,688.39 Cr | 1,626.89 Cr | 2,061.50 Cr | 0.5589 | 63.87 Cr | 147.68 Cr | -79.70 Cr | -230.90 Cr | -25.63 | 502.73 Cr | -0.0626 |
| 2022-03-31 | 3,022.06 Cr | 1,583.28 Cr | 1,438.77 Cr | 0.4761 | 89.39 Cr | 151.21 Cr | -282.43 Cr | -474.25 Cr | -52.84 | -134.56 Cr | -0.1569 |
| 2021-03-31 | 3,251.16 Cr | 1,408.78 Cr | 1,842.38 Cr | 0.5667 | 105.91 Cr | 115.13 Cr | 456.92 Cr | 268.44 Cr | 28.40 | 725.04 Cr | 0.0826 |
| 2020-03-31 | 2,656.75 Cr | 1,183.98 Cr | 1,472.76 Cr | 0.5543 | 103.97 Cr | 115.10 Cr | 208.16 Cr | 36.39 Cr | 2.70 | 486.41 Cr | 0.0137 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 161.02 Cr | 5,839.76 Cr | 3,768.05 Cr | 2,125.5630 Cr | 2,516.87 Cr | 2,355.85 Cr | 1,126.24 Cr | 977.30 Cr | 26.04 Cr | 0.00 Cr | 72.97 Cr | 2,879.2590 Cr |
| 2023-03-31 | 303.50 Cr | 6,638.42 Cr | 4,465.54 Cr | 2,212.2580 Cr | 3,029.57 Cr | 2,726.07 Cr | 1,146.51 Cr | 1,372.55 Cr | 32.45 Cr | 0.00 Cr | 324.74 Cr | 2,990.2010 Cr |
| 2022-03-31 | 170.73 Cr | 6,975.86 Cr | 4,592.55 Cr | 2,359.2280 Cr | 3,025.03 Cr | 2,854.30 Cr | 1,173.80 Cr | 1,513.64 Cr | 28.12 Cr | 0.00 Cr | -22.73 Cr | 3,411.6750 Cr |
| 2021-03-31 | 125.83 Cr | 7,015.02 Cr | 4,201.02 Cr | 2,776.6610 Cr | 2,348.23 Cr | 2,222.39 Cr | 1,200.70 Cr | 1,499.45 Cr | 239.96 Cr | 323.37 Cr | 462.94 Cr | 2,738.3480 Cr |
| 2020-03-31 | 182.23 Cr | 6,151.73 Cr | 3,557.08 Cr | 2,527.4170 Cr | 2,234.66 Cr | 2,052.43 Cr | 782.54 Cr | 1,463.94 Cr | 362.97 Cr | 133.33 Cr | 268.00 Cr | 2,544.8570 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 701.0650 Cr | -150.2500 Cr | -693.3230 Cr | 582.9140 Cr | -142.4810 Cr | 161.0200 Cr | -118.1510 Cr | -62.7240 Cr | -384.4560 Cr | -13.5170 Cr | 30.7040 Cr |
| 2023-03-31 | 44.4110 Cr | 302.4740 Cr | -213.9210 Cr | -50.5270 Cr | 132.7710 Cr | 303.5010 Cr | -94.9380 Cr | -267.6310 Cr | 24.9280 Cr | 0.0000 Cr | -8.1380 Cr |
| 2022-03-31 | -257.8150 Cr | -118.7330 Cr | 421.3160 Cr | -401.1980 Cr | 44.8960 Cr | 170.7300 Cr | -143.3830 Cr | -652.5130 Cr | 137.4920 Cr | -22.4310 Cr | 28.1860 Cr |
| 2021-03-31 | 481.4370 Cr | -520.8210 Cr | -15.7960 Cr | 183.9530 Cr | -56.4000 Cr | 125.8340 Cr | -297.4840 Cr | 289.3800 Cr | 174.9380 Cr | -17.9150 Cr | -414.0490 Cr |
| 2020-03-31 | 204.7870 Cr | 1,306.1590 Cr | -1,709.4490 Cr | 54.7850 Cr | -183.6550 Cr | 182.2340 Cr | -150.0020 Cr | 48.5080 Cr | -1,349.6130 Cr | -153.8950 Cr | -162.5240 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,153.67 Cr | 480.12 Cr | 673.54 Cr | 0.5838 | 161.89 Cr | 87.95 Cr | 9.56 | 214.45 Cr | 0.0762 |
| 2024-09-30 | 1,201.11 Cr | 767.86 Cr | 433.25 Cr | 0.3607 | 185.28 Cr | 93.23 Cr | 10.14 | 247.54 Cr | 0.0776 |
| 2024-06-30 | 1,087.51 Cr | 681.21 Cr | 406.30 Cr | 0.3736 | 168.39 Cr | 70.20 Cr | 7.64 | 225.96 Cr | 0.0646 |
| 2024-03-31 | 1,084.04 Cr | 665.15 Cr | 418.88 Cr | 0.3864 | 179.97 Cr | 18.18 Cr | 1.98 | 208.12 Cr | 0.0168 |
| 2023-12-31 | 1,037.67 Cr | 421.24 Cr | 616.43 Cr | 0.5940 | 107.49 Cr | 49.67 Cr | -0.49 | 192.50 Cr | 0.0479 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 130.64 Cr | 204.48 Cr | 335.12 Cr | 0.00 Cr | 1,210.60 Cr | 3,094.02 Cr | 998.77 Cr | 5,989.63 Cr | 3,774.63 Cr |
| 2024-06-30 | -296.92 Cr | 593.85 Cr | 296.92 Cr | 0.00 Cr | 0.00 Cr | 296.92 Cr | 0.00 Cr | 0.00 Cr | -2,071.71 Cr |
| 2024-03-31 | 191.17 Cr | 105.76 Cr | 296.92 Cr | 1,141.87 Cr | 1,126.24 Cr | 2,969.00 Cr | 958.55 Cr | 5,839.76 Cr | 3,768.05 Cr |
| 2023-12-31 | -326.31 Cr | 652.62 Cr | 326.31 Cr | 0.00 Cr | 0.00 Cr | 326.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 98.87 Cr | 334.11 Cr | 432.98 Cr | 0.00 Cr | 1,137.63 Cr | 3,389.21 Cr | 972.52 Cr | 6,337.80 Cr | 4,344.29 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 70.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 18.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 49.67 Cr | 102.46 Cr | 0.00 Cr | 0.00 Cr | 102.46 Cr | 365.64 Cr | 263.19 Cr | 0.00 Cr | 102.46 Cr |
| 2023-09-30 | -131.34 Cr | 120.21 Cr | 0.00 Cr | 0.00 Cr | 120.21 Cr | 263.19 Cr | 142.98 Cr | 0.00 Cr | 120.21 Cr |
| 2023-06-30 | -7.11 Cr | 119.18 Cr | 0.00 Cr | 0.00 Cr | 119.18 Cr | 428.78 Cr | 309.60 Cr | 0.00 Cr | 119.18 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,679.20 | ₹4,028,870,976,000.00 | ₹2,500,031.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,544.50 | ₹1,737,361,870,500.00 | ₹361,018.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,320.90 | ₹1,100,458,988,118.00 | ₹2,158,463.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,154.30 | ₹1,067,557,063,500.00 | ₹86,576.00 |
| Mankind Pharma Limited | MANKIND | ₹2,352.40 | ₹970,767,378,020.00 | ₹353,197.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹960.15 | ₹966,131,734,500.00 | ₹810,089.00 |
| Lupin Limited | LUPIN | ₹1,999.60 | ₹913,207,322,000.00 | ₹1,289,535.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,161.10 | ₹674,369,202,200.00 | ₹392,642.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,862.50 | ₹581,384,812,500.00 | ₹181,782.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,590.20 | ₹448,756,030,200.00 | ₹940,265.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹1,055.10 | ₹403,646,450,141.00 | ₹209,681.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,370.90 | ₹347,802,813,600.00 | ₹594,702.00 |
| Laurus Labs Limited | LAURUSLABS | ₹642.05 | ₹346,227,388,650.00 | ₹1,658,718.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,571.30 | ₹321,186,225,600.00 | ₹84,218.00 |
| Piramal Enterprises Limited | PEL | ₹1,173.70 | ₹266,051,968,600.00 | ₹1,087,297.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,702.30 | ₹265,322,180,300.00 | ₹62,791.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,790.00 | ₹244,750,000,000.00 | ₹123,199.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,505.40 | ₹244,595,886,600.00 | ₹803,276.00 |
| Eris Lifesciences Limited | ERIS | ₹1,638.30 | ₹223,111,885,500.00 | ₹55,563.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹987.60 | ₹194,125,618,800.00 | ₹40,498.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,140.00 | ₹181,580,340,000.00 | ₹116,733.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,030.00 | ₹167,173,597,000.00 | ₹539,376.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,093.30 | ₹159,115,291,610.00 | ₹64,315.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹858.30 | ₹153,730,113,000.00 | ₹354,578.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹529.95 | ₹128,536,192,800.00 | ₹485,798.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,560.50 | ₹92,300,963,700.00 | ₹8,096.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹914.45 | ₹89,424,888,505.00 | ₹310,698.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹909.25 | ₹82,409,528,235.00 | ₹242,116.00 |
| Strides Pharma Science Limited | STAR | ₹782.30 | ₹72,098,880,210.00 | ₹430,298.00 |
| FDC Limited | FDC | ₹429.20 | ₹69,878,052,000.00 | ₹308,089.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹165.55 | ₹53,724,617,100.00 | ₹2,347,837.00 |
| Innova Captab Limited | INNOVACAP | ₹889.10 | ₹50,878,685,263.00 | ₹72,505.00 |
| Suven Life Sciences Limited | SUVEN | ₹221.19 | ₹48,235,788,060.00 | ₹1,475,325.00 |
| Sequent Scientific Limited | SEQUENT | ₹187.85 | ₹47,019,230,700.00 | ₹442,806.00 |
| Hikal Limited | HIKAL | ₹372.35 | ₹45,911,127,350.00 | ₹154,610.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹462.15 | ₹42,180,430,500.00 | ₹112,178.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹592.90 | ₹41,743,598,820.00 | ₹18,878.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹368.10 | ₹36,912,331,800.00 | ₹50,918.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹718.15 | ₹36,423,921,665.00 | ₹149,821.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,141.70 | ₹35,421,576,300.00 | ₹12,390.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹64.12 | ₹35,134,810,480.00 | ₹2,840,731.00 |
| Alembic Limited | ALEMBICLTD | ₹112.07 | ₹28,777,558,628.00 | ₹591,652.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹88.74 | ₹26,047,585,980.00 | ₹1,118,303.00 |
| Indoco Remedies Limited | INDOCO | ₹275.10 | ₹25,377,397,290.00 | ₹25,198.00 |
Key Executives
Senior Vice President of Strides Pharma Inc.
Mr. Kevin P. Cook
Gender: male
Year Born:
Executive Director of Business Development & Director
Mr. Aditya Arun Kumar
Gender: male
Year Born:
Founder & Non-Executive Chairperson
Mr. Arun Kumar Pillai B.Com.
Gender: male
Year Born: 1961
Chief Operating Officer
Mr. P. V. S. Ramaraju
Gender: male
Year Born:
Compliance Officer & Company Secretary
Ms. Manjula Ramamurthy
Gender: female
Year Born:
Group Chief Human Resource Officer
Ms. Surabhi Loshali
Gender: female
Year Born: 1980
MD & Group Chief Executive Officer
Mr. Badree Komandur
Gender: male
Year Born: 1972
Group General Counsel, Chief Risk Officer & Chief Sustainability Officer
Sormistha Ghosh
Gender: Not Specified
Year Born:
Executive Vice President of Operations
Mr. C. K. Sundar
Gender: male
Year Born:
Group Chief Financial Officer & Chief Investor Relations Officer
Mr. Vikesh Kumar
Gender: male
Year Born: 1985
FAQs about Strides Pharma Science Limited
Who is the CEO of the company?
The CEO is Mr. Badree Komandur.
What is the current market price of the stock?
The current price is ₹782.30.
What is the 52-week price range?
The range is ₹513.05-1675.
What is the market capitalization of the company?
The market capitalization is ₹7,209.89 crores.
What is the dividend yield?
The dividend yield is 0.32%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 26.70.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Strides Pharma Science Limited (ISIN: INE939A01011) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹7,209.89 crores and an average daily volume of 584,801 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹2.5.